These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 13454430)
41. [Results of viomycin therapy of tuberculosis in children]. Petrykowska-Janik H Gruzlica; 1966 Feb; 34(2):131-4. PubMed ID: 4287526 [No Abstract] [Full Text] [Related]
42. [Viomycin and viomycin pantothenate with reduced toxicity in therapy of pulmonary tuberculosis]. KUNTZ E Arzneimittelforschung; 1957 Apr; 7(4):233-7. PubMed ID: 13436325 [No Abstract] [Full Text] [Related]
43. [Resistance of tubercle bacilli to cycloserine, viomycin and ethionamide in patients suffering from pulmonary tuberculosis]. Srednicka-Zajac D; Mysakowska H; Szarewicz-Adamczyk W; Litwin B Ann Univ Mariae Curie Sklodowska Med; 1967; 22():71-8. PubMed ID: 4308440 [No Abstract] [Full Text] [Related]
44. [Side effects in viomycin therapy of pulmonary tuberculosis]. LEMMING R; MELLANDER R Sven Lakartidn; 1954 Nov; 51(45):2854-8. PubMed ID: 13216623 [No Abstract] [Full Text] [Related]
46. [Clinical study on tuberactinomycin-N (TUM-N) and viomycin (VM) in retreatment of pulmonary tuberculosis (author's transl)]. Kekkaku; 1974 Jul; 49(7):207-15. PubMed ID: 4372439 [No Abstract] [Full Text] [Related]
47. [Tolerance to viomycin, at the same time a report on experience with intravenous application]. Bloedner CD Prax Pneumol; 1967 Mar; 21(3):152-6. PubMed ID: 4299050 [No Abstract] [Full Text] [Related]
48. [Use of viomycin in the treatment of tuberculosis; posology, means of administration and secondary toxic action]. GIUSTI M Riv Clin Pediatr; 1955 Oct; 56(4):325-49. PubMed ID: 13290584 [No Abstract] [Full Text] [Related]
50. [Clinical tests of viomycin-pantothenatesulfate (vionactan-P)]. ARNOLD M Schweiz Z Tuberc Pneumonol; 1958; 15(4):203-10. PubMed ID: 13602779 [No Abstract] [Full Text] [Related]
51. [Th-1314 in combination with viomycin and terramycin in the treatment of pulmonary tuberculosis in the Negro race (apropos of 51 cases)]. BAUDRY A Acta Tuberc Pneumol Belg; 1961; 52():40-78. PubMed ID: 13687876 [No Abstract] [Full Text] [Related]
52. [Two years of experience with viomycin pantothenate-sulfate (vionactan) in the treatment of pulmonary tuberculosis]. SCALFI GF; PONTIGGIA P; ROSSA G Minerva Med; 1958 Sep; 49(71):3343-56. PubMed ID: 13600139 [No Abstract] [Full Text] [Related]
53. [Contribution to the study of intravenous viocin used alone in heroic treatment of pulmonary tuberculosis]. Masselot I; Meslier de Rocan J Rev Tuberc Pneumol (Paris); 1965 Apr; 29(4):353-63. PubMed ID: 4284231 [No Abstract] [Full Text] [Related]
54. [Effect of viomycin on the labyrinthine, sensory and retinal chronaxy in subjects with lung tuberculosis]. Fafrowicz B; Kamyszew A Ann Acad Med Stetin; 1970; 16():417-24. PubMed ID: 4339298 [No Abstract] [Full Text] [Related]
56. [Therapy of pulmonary tuberculosis with reserve drugs in the light of our personal observations]. Kochnowski G Wiad Lek; 1970 Jan; 23(1):9-13. PubMed ID: 4312765 [No Abstract] [Full Text] [Related]
57. [Original treatment of pulmonary tuberculosis by enviomycin (EVM)]. Ogiwara S Kekkaku; 1987 Sep; 62(9):459-67. PubMed ID: 2828742 [No Abstract] [Full Text] [Related]
58. Viomycin therapy in human tuberculosis. SCHAFFELD HG; GARTHWAITE B; AMBERSON JB Am Rev Tuberc; 1954 Apr; 69(4):520-42. PubMed ID: 13148513 [No Abstract] [Full Text] [Related]